
FDA grapples with gray areas in fast-tracking experimental drugs
Gray areas create agonizing conundrums for agency officials and patient advocates.
Gray areas create agonizing conundrums for agency officials and patient advocates.
The two Ebola-infected Americans recently evacuated from Liberia were given an experimental drug that probably saved their lives, but Popular Science raises an interesting point – no Africans are likely to get the same treatment. Not anytime soon, that is. Kent Brantly and Nancy Writebol, the two volunteers in an Ebola clinic that contracted the deadly virus, […]